Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

被引：0

作者：

Kalincik, T. ^{[1
]}

Jokubaitis, V. ^{[2
]}

Spelman, T. ^{[2
]}

Horakova, D. ^{[3
,4
,5
]}

Havrdova, E. ^{[3
,4
,5
]}

Trojano, M. ^{[6
]}

Lechner-Scott, J. ^{[7
]}

Lugaresi, A. ^{[8
]}

Prat, A. ^{[9
]}

Girard, M. ^{[9
]}

Duquette, P. ^{[9
]}

Grammond, P. ^{[10
]}

Solaro, C. ^{[11
]}

Grand'Maison, F. ^{[12
]}

Hupperts, R. ^{[13
]}

Prevost, J. ^{[14
]}

Sola, P. ^{[15
]}

Ferraro, D. ^{[15
]}

Terzi, M. ^{[16
]}

Butler, E. ^{[17
]}

Slee, M. ^{[18
]}

Kermode, A. ^{[19
]}

Fabis-Pedrini, M. ^{[19
]}

McCombe, P. ^{[20
]}

Barnett, M. ^{[21
]}

Shaw, C. ^{[22
]}

Hodgkinson, S. ^{[23
]}

Butzkueven, H. ^{[2
]}

机构：

[1] Royal Melbourne Hosp, Dept Neurol, CORe, Melbourne, Vic, Australia

[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

[3] Gen Univ Hosp, Dept Neurol, Prague, Czech Republic

[4] Gen Univ Hosp, Ctr Clin Neurosci, Prague, Czech Republic

[5] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[6] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy

[7] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia

[8] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy

[9] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada

[10] CISSS Chaudiere Appalache, Levis, PQ, Canada

[11] Osped PA Micone, Genoa, Italy

[12] Neuro Rive Sud, Quebec City, PQ, Canada

[13] Zuyderland Ziekenhuis, Sittard, Netherlands

[14] CSSS St JErUme, St Jerome, PQ, Canada

[15] Univ Modena, Dept Biomed Metab & Neurosci, Modena, Italy

[16] 19 Mayis Univ, Fac Med, Samsun, Turkey

[17] Monash Med Ctr, Melbourne, Vic, Australia

[18] Flinders Univ S Australia, Adelaide, SA, Australia

[19] Univ Western Australia, Perth, WA, Australia

[20] Univ Queensland, Brisbane, Qld, Australia

[21] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia

[22] Geelong Hosp, Geelong, Vic, Australia

[23] Liverpool Hosp, Sydney, NSW, Australia

来源：

MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷

基金：

加拿大健康研究院;

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1138

引用

页码：596 / 597

页数：2

共 50 条

[1] Cladribine versus fingolimod, natalizumab and interferon for multiple sclerosis
Kalincik, Tomas
Jokubaitis, Vilija
Spelman, Tim
Horakova, Dana
Havrdova, Eva
Trojano, Maria
Lechner-Scott, Jeannette
Lugaresi, Alessandra
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Grammond, Pierre
Solaro, Claudio
Grand'Maison, Francois
Hupperts, Raymond
Prevost, Julie
Sola, Patrizia
Ferraro, Diana
Terzi, Murat
Butler, Ernest
Slee, Mark
Kermode, Allan
Fabis-Pedrini, Marzena
McCombe, Pamela
Barnett, Michael
Shaw, Cameron
Hodgkinson, Suzanne
Butzkueven, Helmut
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1617 - 1626
[2] Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis (vol 23, pg 596, 2017)
Kalincik, T.
Jokubaitis, V
Spelman, T.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (14)
[3] Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis
Iaffaldano, Pietro
Lucisano, Giuseppe
Pozzilli, Carlo
Morra, Vincenzo Brescia
Ghezzi, Angelo
Millefiorini, Enrico
Patti, Francesco
Lugaresi, Alessandra
Zimatore, Giovanni Bosco
Marrosu, Maria Giovanna
Amato, Maria Pia
Bertolotto, Antonio
Bergamaschi, Roberto
Granella, Franco
Coniglio, Gabriella
Tedeschi, Gioacchino
Sola, Patrizia
Lus, Giacomo
Ferro, Maria Teresa
Iuliano, Gerardo
Corea, Francesco
Protti, Alessandra
Cavalla, Paola
Guareschi, Angelica
Rodegher, Mariaemma
Paolicelli, Damiano
Tortorella, Carla
Lepore, Vito
Prosperini, Luca
Sacca, Francesco
Baroncini, Damiano
Comi, Giancarlo
Trojano, Maria
BRAIN, 2015, 138 : 3275 - 3286
[4] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsingremitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles B.
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (04) : 7 - 8
[5] Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
Zhu, Chao
Zhou, Zhen
Roos, Izanne
Merlo, Daniel
Kalincik, Tomas
Ozakbas, Serkan
Skibina, Olga
Kuhle, Jens
Hodgkinson, Suzanne
Boz, Cavit
Alroughani, Raed
Lechner-Scott, Jeannette
Barnett, Michael
Izquierdo, Guillermo
Prat, Alexandre
Horakova, Dana
Havrdova, Eva Kubala
Macdonell, Richard
Patti, Francesco
Khoury, Samia Joseph
Slee, Mark
Karabudak, Rana
Onofrj, Marco
Van Pesch, Vincent
Prevost, Julie
Monif, Mastura
Jokubaitis, Vilija
van der Walt, Anneke
Butzkueven, Helmut
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (12): : 1330 - 1337
[6] Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
Vollmer, Brandi L.
Nair, Kavita V.
Sillau, Stefan
Corboy, John R.
Vollmer, Timothy
Alvarez, Enrique
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02): : 252 - 262
[7] Rituximab versus Fingolimod after Natalizumab in Multiple Sclerosis Patients
Alping, Peter
Frisell, Thomas
Novakova, Lenka
Islam-Jakobsson, Protik
Salzer, Jonatan
Bjorck, Anna
Axelsson, Markus
Malmestrom, Clas
Fink, Katharina
Lycke, Jan
Svenningsson, Anders
Piehl, Fredrik
ANNALS OF NEUROLOGY, 2016, 79 (06) : 950 - 958
[8] Multiple Sclerosis Is Natalizumab is effective as Fingolimod?
Kilger, Ellen
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 (05) : 256 - 256
[9] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles
Ozakbas, Serkan
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
Alroughani, Raed
Izquierdo, Guillermo
Eichau Madueno, Sara
Boz, Cavit
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Foschi, Matteo
Grand'Maison, Francois
John, Nevin
Grammond, Pierre
Terzi, Murat
Prevost, Julie
Barnett, Michael
Laureys, Guy
Van Hijfte, Liesbeth
Luis Sanchez, Jose
Blanco, Yolanda
Oh, Jiwon
Mccombe, Pamela
Ramo Tello, Cristina
Soysal, Aysun
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Yamout, Bassem I.
Khoury, Samia
Van Pesch, Vincent
Macdonell, Richard
Sa, Maria Jose
Slee, Mark
Kuhle, Jens
Maimone, Davide
Spitaleri, Daniele L. A.
Willekens, Barbara
Al-Asmi, Abdullah
Robertson, Neil
Coles, Alasdair
Brown, J. William L.
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 629 - 631
[10] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
Roos, Izanne
Sharmin, Sifat
Malpas, Charles
Ozakbas, Serkan
Lechner-Scott, Jeannette
Hodgkinson, Suzanne
Alroughani, Raed
Eichau Madueno, Sara
Boz, Cavit
van der Walt, Anneke
Butzkueven, Helmut
Buzzard, Katherine
Skibina, Olga
Foschi, Matteo
Grand'Maison, Francois
John, Nevin
Grammond, Pierre
Terzi, Murat
Prevost, Julie
Barnett, Michael
Laureys, Guy
Van Hijfte, Liesbeth
Luis Sanchez-Menoyo, Jose
Blanco, Yolanda
Oh, Jiwon
Mccombe, Pamela
Ramo Tello, Cristina
Soysal, Aysun
Prat, Alexandre
Duquette, Pierre
Yamout, Bassem, I
Khoury, Samia
van Pesch, Vincent
Macdonell, Richard
Jose Sa, Maria
Slee, Mark
Kuhle, Jens
Maimone, Davide
Spitaleri, Daniele L. A.
Willekens, Barbara
Asmi, Abdallah Al
Tallantyre, Emma
Robertson, Neil P.
Coles, Alasdair
Brown, J. William
Kalincik, Tomas
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : 1163 - 1175

← 1 2 3 4 5 →